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Abstract Tumor necrosis factor (TNF) plays a central role in
the state of insulin resistance leading to type II diabetes. We here
describe the crosstalk of TNF with insulin signaling cascades in
the mouse muscle cell line pmi28. TNF downregulated insulin
induced insulin receptor kinase activity and insulin induced
activation of the transcription factor STAT5. Our results provide
evidence that the inhibitory crosstalk between TNF and insulin in
skeletal muscle cells comprises an interference with the expres-
sion of STAT5 regulated genes which may play an important role
in the manifestation and/or progression of insulin resistance in
muscle cells.
z 1998 Federation of European Biochemical Societies.
Key words: Insulin resistance; Tumor necrosis factor;
Skeletal muscle; STAT5
1. Introduction
Insulin plays a key role for the regulation of metabolism in
many mammalian cells, and many components of the insulin
signaling network have been identi¢ed (for review see White
and Kahn [1]). The major intracellular substrates of the in-
sulin receptor tyrosine kinase (IRL) are insulin receptor sub-
strates IRS-1 and IRS-2, which act as an interface between
stimulated receptors and signaling proteins with SRC homol-
ogy 2 (SH2) domains, and upon phosphorylation bind a vari-
ety of signaling molecules including PI-3 kinase, Syp, Nck,
Grb2 and Fyn. In addition to IRS, the SH2/SH3 domain
containing adapter, Shc, has been shown to directly interact
with the IR. An additional physiological substrate of the in-
sulin receptor, STAT5 (signal transducer and activator of
transcription), has recently been described which, unlike the
cytokine mediated activation of STATs, appears to be inde-
pendent of JAK [2]. Thus, STAT5 is likely to participate in
the regulation of the transcriptional program of insulin re-
sponsive tissues. In support of this, STAT5A3/3 and
STAT5B3/3 knockout mice have been examined and each
mutant shows a highly speci¢c phenotype with female lacta-
tion defects in STAT5A3/3 mice and male growth retarda-
tion as well as development of obesity in STAT5B3/3 ani-
mals [3,4].
Insulin resistance is de¢ned as the reduced ability of cells or
tissues to respond to physiological levels of insulin and is a
characteristic condition of early stage non-insulin dependent
diabetes mellitus (NIDDM) [5]. Obesity is the strongest risk
factor for NIDDM. Insulin resistance has also been described
in a number of disease conditions including cancer, sepsis,
endotoxemia, trauma and alcoholism [6]. These conditions
are known to cause altered levels of cytokine expression. In
particular, TNF has been recognized as an important media-
tor associated with the above disease states including obesity:
the expression of TNF is increased in adipose tissue and skel-
etal muscle cells of obese, diabetic patients [7,8] and TNF
alters protein and lipid metabolism in adipose tissue [9].
Of relevance, knockout mice devoid of either the TNF-K
gene or the two TNFR genes develop insulin resistance nei-
ther in a diet induced nor in a genetically determined (ob/ob)
obesity model [10], pointing to the essential contribution of
TNF in the acquisition of this disease state. As to the molec-
ular mechanisms of TNF action, it is apparent from several
studies with a¡ected tissues [10,11] and from in vitro cell
culture models [12] that IR kinase activity and downstream
signaling events are a¡ected. So far, in vitro models of insulin
resistance are based on cell lines of liver or fat tissue origin
and have focused on the crosstalk of TNF with insulin at the
level of IRS-1 and 2 [13]. From these studies, the time course
of TNF e¡ects on IR signaling and the mechanisms of action
appears to di¡er depending on the cell types analyzed
[12,14,15]. In particular, the relevance of serine phosphoryla-
tion of IRS-1 and/or IRS-2 versus downregulation of protein
levels of these molecules remains unresolved at present. Other
potential targets in the diverse signal pathways emanating
from the IR and their role in development of insulin resistance
have not been studied so far.
We here describe a new cellular model, the murine muscle
cell line pmi28, that retains in vitro di¡erentiation potential
and expresses markers characteristic of di¡erentiated muscle
such as sarcomeric myosin [16^18]. This cell line, upon di¡er-
entiation, is both TNF and insulin responsive and represents a
suitable model for studying the crosstalk between TNF and
insulin signaling cascades. Evidence is presented that this in-
teraction occurs not only by reduction of IR phosphorylation
but also at the transcriptional level by inhibition of STAT5
activation.
2. Materials and methods
2.1. Cell culture
Myoblasts from a primary culture designated pmi28 were used
[17,18]. The culture was established from the hind-leg muscles of a
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7 day old male BALB/c mouse. Initial expansion and enrichment in
myoblasts was achieved by repeated replating and growth in minimum
essential medium with D-valine (Gibco BRL) containing 20% fetal
bovine serum (FBS). When the expanded culture was highly enriched
(100% myoblasts as evaluated by immuno£uorescent staining for des-
min), the cells were further propagated in F10 medium. Pmi28 myo-
blasts expanded over 2^6 passages have been implanted in vivo and
shown, among several other expanded primary cultures, to integrate
into and improve muscle contractile strength in syngeneic animals
[17]. Pmi28 cells have been propagated in vitro over 40 passages with-
out loss of myogenic properties or proliferative capacity [17]. In the
present experiments, the mouse myoblast cell line pmi28 was cultured
in nutrient mixture Ham’s F10 (Biochrom) supplemented with 20%
FCS (PAA). For di¡erentiation pmi28 cells were grown to con£uence
in tissue culture plates for primary cell culture (Sarstedt) and medium
was changed into low glucose (1 g/l) Dulbecco’s MEM (Biochrom)
supplemented with 10% horse serum for 2 days (Gibco BRL), result-
ing in the formation of syncytia. Prior to the experiments, di¡erenti-
ated pmi28 cells were serum starved and as indicated preincubated
with TNF (50 ng/ml) for 2 h and stimulated with insulin (200 nM) for
10 min or for the indicated times.
2.2. Cytokines, antibodies and reagents
Recombinant huTNF was a kind gift of BASF and insulin from
bovine pancreas was from Sigma. Monoclonal antibodies against sar-
comeric myosin (MF-20) were a kind gift of Prof. Dr. Anna Starzin-
ski-Powitz (University of Frankfurt/M, Germany). Antibodies against
insulin receptor L (C-19), STAT5 (G-2) and phosphotyrosine (PY99)
were from Santa Cruz. All inhibitors of proteases and phosphatases
were from Biomol. Secondary AP linked antibodies, goat anti-mouse
IgG and IgM (H+L) and goat anti-rabbit IgG (H+L), were from
Dianova. NF-UB oligonucleotides (5P-ATCAGGGACTTTCCGCTG-
GGGACTTTCCG-3P) were synthesized by MWG and STAT5 oligo-
nucleotides (5P-AGATTTCTAGGAATTCAATCC-3P) and mutant
oligonucleotides (CTAGGCAGTTT substitution in the STAT5 bind-
ing motif) were from Santa Cruz.
2.3. Immuno£uorescence
Cells were washed and ¢xed with 3.5% paraformaldehyde for 10
min, rinsed three times with PBS and once with 0.15 M glycine in
PBS. The cells were permeabilized with 0.1% SDS for 1 min, blocked
with blocking bu¡er (5% goat serum and 0.05% Tween in PBS) for 30
min and washed three times with PBS. After incubation with MF-20
primary antibody (1:10) in blocking bu¡er for 2 h, the slides were
rinsed three times with PBS and then incubated with secondary CY3
linked antibody in blocking bu¡er for 1.5 h. Rinsing with PBS (four
or ¢ve times) was followed by mounting with Mowiol.
2.4. Immunoprecipitation
After stimulation the cells were washed twice with PBS (4‡C) and
scraped in 750 Wl ice-cold phosphorylation bu¡er (50 mM HEPES pH
7.8, 2.5 mM EDTA, 1% Triton X-100, 150 mM saccharose, 100 mM
NaF, 10 mM NaPP, 2 mM sodium orthovanadate, 1 mM sodium
molybdate, 100 nM okadaic acid, 100 nM calyculin A, 1 mM p-nitro-
phenyl phosphate, 1 Wg/ml leupeptin, 1 Wg/ml aprotinin, 1 mM PMSF)
or in WCL (0.5% NP-40, 50 mM Tris-HCl pH 7.4, 0.1 mM EDTA,
150 mM NaCl, 10% glycerol, 1 mM NaF, 1 mM NaPP, 2 mM sodium
orthovanadate, 1 mM sodium molybdate, 100 nM okadaic acid, 100
nM calyculin A, 1 mM p-nitrophenyl phosphate, 1 Wg/ml leupeptin,
1 Wg/ml aprotinin, 1 mM PMSF). After soni¢cation and cell lysis, the
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Fig. 1. Di¡erentiation of pmi28 primary myoblasts into muscle syncytia. Pmi28 myoblasts were grown to con£uence and di¡erentiation medium
was added for 2 days. Immuno£uorescence staining against myosin (MF-20) was performed as described in Section 2. a: Phase contrast of un-
di¡erentiated cells. b: MF-20 immuno£uorescence staining of undi¡erentiated cells. c: Phase contrast of di¡erentiated cells. d: MF-20 immuno-
£uorescence staining of di¡erentiated cells.
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lysates were centrifuged (10 000 rpm, 15 min, 4‡C) and immunopreci-
pitation was performed as described [19].
2.5. Kinase assay
The cells were lysed as described above. After immunoprecipitation
of IRL, the protein A pellets were washed thrice with bu¡er C [19] and
resuspended in 30 Wl of kinase bu¡er (20 mM Tris-HCl pH 7.4, 50
mM NaCl, 10 mM MgCl2). After addition of 4 WCi [Q-32P]ATP
(Amersham) in 10 Wl kinase bu¡er, the samples were incubated for
15 min at 37‡C. The reaction was stopped with equal amounts of 2U
reducing Laemmli bu¡er and the samples were separated on 7.5%
SDS-PAGE and blotted onto nitrocellulose. Analysis of the kinase
assays was performed with a phosphorimager (Molecular Dynamics).
2.6. Electrophoretic mobility shift assay (EMSA)
Oligonucleotides were 32P-labeled with polynucleotide kinase and
EMSA was performed as described [19].
3. Results
3.1. Di¡erentiation of pmi28 cells
Myoblasts from an expanded primary culture of a male
BALB/c mouse skeletal muscle described in [17,18] were dif-
ferentiated according to Section 2. After 2 days of di¡erentia-
tion the cells exhibited the typical phenotype of polynucleated
(syncytia) muscle ¢bers. In order to determine the number of
di¡erentiated cells, expression of a speci¢c muscle di¡erentia-
tion marker, sarcomeric myosin [16], was analyzed by immu-
no£uorescence microscopy with antibody MF-20 (Fig. 1). In
all experiments described below, at least 90% of the cells ex-
pressed this di¡erentiation marker.
3.2. Di¡erentiated pmi28 cells express functional insulin and
TNF signal pathways
To verify the function of the IR signaling cascade and to
establish optimum experimental conditions for studies of
TNF-insulin crosstalk, ¢rst the kinetics of IRL tyrosine phos-
phorylation was analyzed by Western blot with a phosphoty-
rosine speci¢c antibody. Upon insulin treatment of di¡eren-
tiated pmi28 cells, IRL was tyrosine phosphorylated
approximately 60% of maximum within 1 min of stimulation,
indicating that this activation is an extremely rapid process,
reaching its peak after 10 min and remaining at a high acti-
vation level for the time period analyzed (60 min, Fig. 2a).
TNF mediated inhibition of insulin signal pathways in adi-
pocytes and hepatocytes has been associated with TNFR1
signaling [15,20]. To investigate whether di¡erentiated pmi28
cells respond to TNF treatment, cells were treated with hu-
man TNF, which selectively binds to and activates murine
TNFR1, but not TNFR2 [21], and activation of NF-UB as
a typical TNF response was measured by EMSA. Nuclear
translocation of NF-UB was observed with a typical maximum
after 30 min of TNF treatment, indicating intact TNFR1
signaling in di¡erentiated pmi28 cells ; as expected, insulin
did not induce NF-UB in these cells (Fig. 2b). Accordingly,
in di¡erentiated pmi28 cells, both insulin and TNF signal
pathways are operative.
3.3. Inhibition of insulin induced tyrosine phosphorylation of
IRL by TNF
To examine the potential crosstalk of TNF with insulin
signal pathways in pmi28, cells pretreated with TNF were
subsequently stimulated with insulin for 10 min, a time point
of maximum tyrosine phosphorylation of IRL in cells not
pretreated with TNF (Fig. 2). Immunoprecipitates from cell
extracts were blotted and probed with phosphotyrosine spe-
ci¢c antibodies. In addition, kinase activity of IR was tested in
an in vitro immunocomplex kinase assay. Compared to un-
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Fig. 2. Kinetics of insulin induced tyrosine phosphorylation of IRL
in di¡erentiated pmi28 cells. Di¡erentiated pmi28 cells were serum
starved for 2 h and stimulated with insulin (200 nM). a: Cells were
lysed in phosphorylation bu¡er, immunoprecipitated, samples sepa-
rated on SDS-PAGE, blotted to nitrocellulose and stained with PY
or IRL antibodies. All experiments were performed three times with
similar results. b: TNF induced signaling evaluated by NF-UB
translocation in di¡erentiated pmi28 cells. Di¡erentiated pmi28 cells
were serum starved for 2 h and stimulated with TNF (50 ng/ml) or
insulin (500 nM) for 10, 30 or 60 min. Nuclear extracts were pre-
pared and incubated with NF-UB oligonucleotide. The gel was dried
and imaged on a phosphorimager.
Fig. 3. In£uence of TNF and insulin on tyrosine phosphorylation of
IRL in pmi28 muscle cells. Cells were serum starved and preincu-
bated with TNF (50 ng/ml). After stimulation with insulin (500 nM)
for 10 min the cells were lysed in phosphorylation bu¡er. IRL im-
munoprecipitates were run on SDS-PAGE and blotted to nitrocellu-
lose. a: The blot was stained with PY or IRL antibodies. b: Kinase
assay with immunoprecipitated IRL receptor (insert) as described in
Section 2 and densitometric evaluation of the kinase assay. Experi-
ments were performed three times with similar results.
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treated control cells, TNF pretreatment for 2 h resulted in an
approximately 40% and 50% decrease of insulin stimulated
tyrosine kinase activity of IR, as revealed by Western blotting
(Fig. 3a) and in vitro autophosphorylation activity (Fig. 3b).
Neither the amount of expressed IR nor its electrophoretic
mobility was changed during a TNF pretreatment period of
up to 2 h (Fig. 3a). Accordingly, the di¡erentiated mouse
muscle cell line pmi28 exerts a similar TNF interference
with IR activity as shown previously for mouse adipocytes
and the human hepatocarcinoma line HepG2 [20,21].
3.4. Crosstalk between insulin and TNF receptor cascades
at the level of STAT5
Recently STAT5B has been described as a novel physiolog-
ical substrate of the insulin receptor and a role in the physio-
logical regulation of insulin responses has been proposed [2].
STAT5 is expressed in di¡erentiated pmi28 cells. Immunopre-
cipitates from nuclear extracts were assayed for tyrosine phos-
phorylation by Western blotting. As shown in Fig. 4a, STAT5
was tyrosine phosphorylated upon insulin stimulation of
pmi28. This IR action was totally inhibited in cells pretreated
with TNF. To assess a functional activation of STAT5, its
speci¢c DNA binding activity was investigated. Nuclear ex-
tracts were subjected to non-denaturing gel mobility shift as-
says with 32P-labeled double stranded oligonucleotide probes
comprising the STAT5 binding sequence of the L-casein gene
promoter [22]. Band shift analyses of pmi28 nuclear extracts
veri¢ed that insulin stimulates nuclear translocation and
STAT5 DNA binding activity, reaching maximum after 30
min (Fig. 4b). This activation was completely blocked when
cells were preincubated with TNF (Fig. 4b).
4. Discussion
The two major achievements described here are (i) the es-
tablishment of an in vitro model to study molecular mecha-
nisms of insulin resistance in cells derived from the physiolog-
ically most relevant of the a¡ected tissues, the skeletal muscle,
and (ii) the demonstration that, aside from the known down-
regulation of the IR induced signal pathways, the IR mediated
activation of STAT5 is abolished by TNF. Our data thus
open up new perspectives as to the underlying mechanisms
of insulin resistance and point, for the ¢rst time, to a TNF-
insulin crosstalk that becomes manifested at the transcription-
al level with potentially persistent inhibition of STAT5 regu-
lated genes.
The tissue and cell speci¢c patterns of signal pathways
make it necessary to establish suitable cellular models for
each of the a¡ected tissues. The interference occurs at several
independent levels of intracellular signal cascades. For exam-
ple in di¡erent adipocyte models, controversial data exist as to
whether TNF induced insulin resistance is predominantly ac-
complished by a¡ecting the functional state or rather the pro-
tein expression levels of IRS-1 and IRS-1 regulated molecules
[12,14,23].
The murine myoblast cell line studied here, pmi28, di¡ers
from other, previously described cell lines of similar tissue
origin by retention of its in vitro di¡erentiation potential
into polynucleated syncytia. Upon di¡erentiation, these cells
show, with respect to IR kinase activity, a response pattern
that resembles data obtained with biopsies of muscle tissue
from mouse NIDDM models [10], indicating that di¡erenti-
ated pmi28 are suitable for analyses of molecular mechanisms
of TNF-insulin crosstalk.
The principal role of TNF in insulin resistance is stressed
from data recently obtained with obese TNF or TNFR1/2
knockout mice [10], both of which do not acquire insulin
resistance and show, compared to obese wild type mice, a
fully restored IR signal capacity in adipocytes, liver and
muscle. Interestingly, in this in vivo model, obese, insulin
resistant animals presented signi¢cantly reduced protein levels
neither of IR nor of the glucose transporter GLUT4, support-
ing the view that TNF does not primarily promote insulin
resistance by downregulation of protein levels of signal or
e¡ector proteins controlling glucose uptake [10]. Thus, at
present, the common denominator of the di¡erent models of
insulin resistance is the quantitatively and/or qualitatively re-
duced IR kinase activity and insu⁄cient substrate phospho-
rylation as the crucial initiating event. This opens up the pos-
sibility that TNF induced insulin resistance is, at least in part,
due to interference with IR induced signal cascades distinct
from IRS-1/2 and funnelling downstream to unknown targets.
We propose that one candidate, the transcriptional activator
STAT5, could be an important operator in this scenario as an
immediate substrate of IR kinase.
The physiologic function of STAT5 is not yet fully eluci-
dated [24], however, STAT5 is capable of acting in concert
with other transcription factors, in a bimodal way, for exam-
ple, with the glucocorticoid receptor. Activated STAT5 antag-
onizes glucocorticoid action at the glucocorticoid responsive
elements and glucocorticoids synergize with STAT5 at speci¢c
STAT5 response elements [25,26], providing a link to gluco-
corticoid modulation of glucose homeostasis [27]. The poten-
tial role of STAT5 in acquisition of NIDDM is supported by
very recent observations made in STAT5B knockout mice,
which, besides other defects, develop obesity [4]. It will be
interesting to see whether or not these animals are prone to
NIDDM. The relevance of STAT5 and other members of this
family of transcription factors is further underscored by the
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Fig. 4. Inhibition of insulin induced activation of STAT5 by TNF
in di¡erentiated pmi28 cells. a: Tyrosine phosphorylation of
STAT5. Cells were serum starved and preincubated with TNF (50
ng/ml) for 2 h. After stimulation with insulin (200 nM) for 30 min
the cells were lysed with WCL bu¡er. STAT5 was immunoprecipi-
tated, separated on SDS-PAGE and transferred to nitrocellulose
membrane. The blot was stained with PY or STAT5 antibodies.
b: EMSA of STAT5. Di¡erentiated pmi28 cells were pretreated
with TNF for 2 h and/or stimulated with insulin (200 nM) for 15
or 30 min. Nuclear extracts were prepared and incubated with
STAT5 oligonucleotide or mutant oligonucleotide de¢cient in
STAT5 binding. The gel was dried and imaged on a phosphorimag-
er. Experiments were performed three times with similar results.
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interesting ¢nding, that in diabetic (db/db) mice expressing a
defective leptin receptor, defective STAT3, 5 and 6 signaling
was found, suggesting an important role of these transcription
factors in mediating the anti-obesity e¡ects of leptin [28]. Sim-
ilar to TNF, leptin has also been implicated in the crosstalk
with insulin signaling cascades [29].
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